Long survival of never smoking non-small cell lung cancer (NSCLC) patients (pts) treated with erlotinib HCI (OSI-774) and chemotherapy: Sub-group analysis of TRIBUTE Meeting Abstract
| Authors: | Miller, V. A.; Herbst, R.; Prager, D.; Fehrenbacher, L.; Hermann, R.; Hoffman, P.; Johnson, B.; Sandler, A. B.; Kris, M. G.; Ramies, D. |
| Abstract Title: | Long survival of never smoking non-small cell lung cancer (NSCLC) patients (pts) treated with erlotinib HCI (OSI-774) and chemotherapy: Sub-group analysis of TRIBUTE |
| Meeting Title: | 40th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 22 |
| Issue: | 14 Suppl. |
| Meeting Dates: | 2004 Jun 5-8 |
| Meeting Location: | New Orleans, LA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2004-07-15 |
| Start Page: | 631S |
| Language: | English |
| ACCESSION: | WOS:000223512402502 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2004.22.90140.7061 |
| Notes: | Meeting Abstract: 7061 -- 40th Annual Meeting of the American-Society-of-Clinical-Oncology -- JUN 05-08, 2004 -- New Orleans, LA -- S -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
